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Abstract: Objectives: Diabetes and hypertension are major risk factors for cardiovascular disease, a leading cause of 
death in humans. The aim of our study was to determine the prevalence of hypertension, and hypertension control among 
adults with diabetes in Basrah (Southern Iraq). 
Methods: A prospective cohort study was conducted at Al-Faiha Diabetes and Endocrine Center in Basrah. It was started 
in August 2008 to April 2011. The total number of recruited patients with diabetes was 5578. 
Results: Hypertensive diabetic patients constituted 89.6% of this study cohort, with 45.3% of them newly discovered in 
the center. From hypertensive patients, 48.2% achieved the target blood pressure of less than 130/80 mmHg. The results  
of the multivariate analyses showed that the factors independently associated with the hypertension were aged > 50 years 
(odds ratio, 0.4; 95% CI, 0.3 to 0.5; p < 0.001), body mass index equal or more than 25 (odds ratio, 0.5; 95% CI, 0.4 to 
0.6; p < 0.001), insulin use (odds ratio, 0.6; 95% CI, 0.5 to 0.8; p < 0.001) and duration of diabetes > 5 years (odds ratio, 
0.6; 95% CI, 0.5 to 0.7; p < 0.001) . 
Conclusion: This study confirmed that hypertension was seen in ~90% of diabetic patients in Iraq, and approximately half 
of them were achieving target blood pressure level. 
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INTRODUCTION 
  Diabetes  and  hypertension  are  major  risk  factors  for 
cardiovascular disease, a leading cause of death in humans 
[1]. Insulin resistance and hyperglycemia combine to make 
hypertension more prevalent in the type 2 diabetic patient 
[2]. Approximately 15% of hypertensive patients are diabetic 
and  approximately  75%  of  Type  2  diabetic  patients  are 
hypertensive [3].  
  The  American  Diabetes  Association  (ADA)  in  2002, 
defined hypertension in diabetic patients as blood pressure 
(BP)  ≥  140/90  mmHg  and  a  target  BP  goal  of  <  130/80 
mmHg is reasonable [4]. For the first time the ADA and the 
Canadian  Diabetes  Association  in  2008  stated  that  repeat 
systolic  BP  ≥  130  mmHg  or  diastolic  BP  ≥80  mmHg 
confirms  a  diagnosis  of  hypertension  in  patients  with 
diabetes mellitus [5,6].  
  The  goal  for  BP  in  the  type  2  diabetic  patients  is  < 
130/80 mmHg, and when significant proteinuria is present at 
120/75 mmHg or below [7-9]. Control of hypertension in the 
diabetic patient to the recommended level of below 130/80 
mmHg has been shown to decrease both the microvascular 
and macrovascular complications of diabetes [2].  
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  The  aim  of  the  study  was  to  determine  prevalence  
of  hypertension,  and  hypertension  control  among  adults  
(18  years  of  age  and  above)  with  diabetes  in  Basrah 
(Southern Iraq). 
METHODS 
Setting  
  A  prospective  cohort  study  was  conducted  at  Al-Faiha 
Diabetes and Endocrine Center in Basrah. This center is the 
only  center  for  this  specialty  in  Southern  Iraq.  Its  tertiary 
referral center received diabetic patients with failure of oral 
antihyperglycemic  drugs  from  primary  health  care  centers 
and hospitals in Basrah. This center started in August 2008 
to concentrate on hypertension control besides glycemic and 
lipid control in patients with diabetes mellitus. Patients age < 
18  years,  those  with  less  than  6  months  of  follow-up, 
defaulters for more than 6 months or pregnant women, were 
excluded.  The  total  recruited  patients  with  diabetes  were 
5578, until end of April 2011. The patients were visiting the 
center every 2 months, and during each visit anthropometric 
studies  were  done  with  measurement  of  BP  and  blood 
glucose and HbA1c according to the indication.  
Definitions of the Variables 
  Duration of diabetes was calculated as the patient’s age at 
the time of the registration in the center minus age at onset of 
diabetes. Body Mass Index (BMI) was calculated as weight 
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  Current  smokers  were  defined  as  those  who  reported 
smoking  >100  cigarettes  during  their  lifetime  and  were 
currently smoking every day or some days. Ex-smokers were 
defined as ever smokers who no longer smoked. 
  BP was measured by a nurse trained in the method using 
a mercury sphygmomanometer and appropriately sized arm 
cuffs after patients rested for 5 min seated. 
  Hypertension  in  diabetic  patients  was  confirmed  if 
systolic  BP  was  equal  or  more  than  130  mmHg  and  or 
diastolic BP equal or more than 80 mmHg on 2 occasions 
separated by at least 1 day or more, or on medications for 
hypertension [10].  
  For new hypertensive patients with a systolic BP of 130 - 
139 mmHg or a diastolic BP of 80 - 89 mmHg, treatment 
was  given  as  lifestyle/behavioral  therapy  alone  for  a 
maximum of 3 months and then, if targets are not achieved, 
they were treated pharmacologically with agents that block 
the  renin-angiotensin  system.  Patients  with  hypertension 
(systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) were 
given drug therapy in addition to lifestyle/behavioral therapy 
[10]. Drug therapy was titrated according to algorithms used 
by most centers [2]. In brief patients started candesartan 8 
mg  once  daily  gradually  increased  dose  until  16  mg  once 
daily  or  enalapril  10  mg  twice  daily,  gradually  increased 
dose to 20  mg twice daily over 2-6 months. If  this failed  
to  achieve  the  target,  hydrochlorothiazide  12.5  mg  once  
daily  was  added,  gradually  increasing  the  dose  to  25  mg 
daily.  Patients  still  having  a  BP  control  out  of  target  
were given amlodipine 5 mg daily as third drug. Patients on 
beta-blockers  for  associated  ischemic  heart  disease  or 
furosemide for heart failure were continued. Patients already 
hypertensive and on medication other than above therapies 
were  changed  to  the  above  drugs  gradually.  Single  agents 
were  enough  to  control  BP  in  15%  of  patients,  2  drugs 
needed in 55% and 3 drugs ultimately needed in 30%. Drugs 
were supplied free of charge. 
  Data analysis was done after April 2011. Any patients 
with  systolic  BP  <  130  mmHg  and  or  diastolic  BP  <  80 
mmHg at the last visit were considered to have controlled 
BP. 
STATISTICAL ANALYSES 
  Statistical  Package  SPSS  for  Windows,  version  18.0 
(SPSS Inc), was used for statistical analysis. The mean ± SD 
was  determined  for  qualitative  data,  and  frequency  for 
categorical  variables.  The  Chi-square  test  was  used  to 
analyze group differences for categorical variables, t-test for 
continuous variables and a p value of <0.05 was considered 
significant.  Multivariate  analyses  using  logistic  regression  
was  used  to  study  factors  independently  associated  with 
hypertension. 
RESULTS  
  More women (Table 1) were included in this study (55.6 
vs 44.4%). The mean age was 51.4 ± 13.7 years, with 56.3% 
of  them  aged  more  than  50  years.  About  70.6%  of  our 
patients were  either overweight or obese.  Current smokers 
constituted  12.8%.  Most  of  the  patients  were  on  insulin 
(71.8%), because of the duty of the center that is explained 
in the methods. The mean duration of diabetes was 8.7 ± 6.9 
years and 62.2% had diabetes for > 5 years. Hypertensive 
patients  constituted  89.6%  of  this  study  cohort,  of  which 
45.3%  were  newly  discovered  in  the  center.  From 
hypertensive  patients,  48.2%  achieved  the  target  of  BP  < 
130/80  mmHg.  There  was  no  statistically  significant 
difference between the 2 hypertension groups (controlled vs 
non-controlled)  as  regards  prevalence  of  cardiovascular 
diseases, proteinuria (overt) or mean HbA1c. 
  Table  2,  shows  variables  associated  with  hypertension. 
Hypertension was higher among women than men (91.0 vs 
88.0%, p < 0.001). The mean age and BMI were higher in 
the hypertensive group (52.3 ± 13.1 vs 43.5 ± 15.9 and 28.2 
± 5.9 vs 25.2 ± 5.7, respectively, p < 0.001). Insulin was used 
more in the hypertensive group (72.2 vs 68.1%, p = 0.03). 
The duration of diabetes was more in the hypertensive group 
(8.9 ± 6.9 vs 7.0 ± 6.3, p < 0.001). 
  The  results  of  the  multivariate  analyses  showed  that  the 
factors  independently  associated  with  the  hypertension 
(Table 3) were age more than 50 years (OR, 0.4; 95% CI, 0.3 
to 0.5; p < 0.001), BMI ≥ 25 (OR, 0.5; 95% CI, 0.4 to 0.6;  
Table 1.  Baseline Characteristics 
Variables    n (%) 
Men   2477(44.4)  Gender  
Women   3101(55.6) 
Mean ± SD  51.4±13.7 
≤50   2434(43.7) 
Age (Years) 
>50  3144(56.3) 
Mean ± SD  27.9±5.9 
Normal weight <25  1632(29.2) 
Overweight 25-29.9  1906(34.1) 
BMI (kg/m 
2) 
Obesity ≥ 30.0  2040(36.5) 
Current   715(12.8) 
Ex-smoker   409(7.3) 
Smoking 
Never   4454(79.8) 
Type 1   536(9.6)  Type of diabetes  
Type 2  5042(90.4) 
Insulin use   4007(71.8) 
Mean ± SD  8.7±6.9 
≤5  2104(37.7) 
Duration of diabetes (years) 
>5   3474(62.2) 
Hypertension     5003(89.6)  
New hypertension   2529 (45.3) 
Controlled hypertension   2414 (48.2)* 
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p  <0.001),  insulin  use  (OR,  0.6;  95%  CI,  0.5  to  0.8;  p  < 
0.001) and duration of diabetes more than 5 years (OR, 0.6; 
95% CI, 0.5 to 0.7; p < 0.001). 
DISCUSSION  
  Hypertension was seen in 89.6 % of our patients, using 
definition  of  systolic  BP  of  130  mmHg  or  above  and  or 
diastolic BP 80 mmHg or above, which is one of the highest 
reported prevalence. Among patients with diabetes mellitus 
in  Jordan  [11,12],  hypertension  was  seen  in  70-72.4% 
(70.9% of males and 73.9% of females). The definition of 
hypertension in that study was BP values of > 130 mmHg 
systolic or > 80 mmHg diastolic.
 
  Among  1952  Saudi  type  2  diabetes  mellitus  patients, 
hypertension  was  present  in  78.1%  (80.5%  of  men  and 
75.8% of women) using the definition of hypertension based 
on a pre-existing history of hypertension or systolic  BP  > 
130 mmHg and/or a diastolic BP > 80 mmHg [13]. In US 
adults  with  diabetes  there  was  an  increased  prevalence  to 
77% if hypertension was defined as ≥130/80 mmHg [14].  
  Of  hypertensive  diabetic  patients  in  this  study,  48.2%  
had  controlled  BP  with  the  ADA  target  <  130/80  mmHg. 
Although  the  large  majority  reported  being  treated  for 
hypertension,  BP  was  controlled  to  the  currently 
recommended level of < 130/80 mmHg in only 30-40% of 
hypertensive, diabetic patients [15,16]. In 2001-2002 more 
than two-thirds of adults with diabetes in the U.S.-Mexico 
border region had uncontrolled BP [17]. In primary health 
care  in Spain  < 10% of diabetics  actually  attain  BP goals 
[18].  This  control  of  BP,  was  even  better  than  glycemic 
control from the same center, where only 25.6 % of diabetics 
achieved a target of HbA1c < 7 % [19].  
  Current  smokers  in  our  study  constituted  12.8%  and 
70.6%  were  overweight  or  obese,  while  15%  of  diabetics 
from  Jordan  were  current  smokers,  and  91%  were  either 
obese or overweight [12].  
  In  our  study,  factors  independently  associated  with 
hypertension were age > 50 years, BMI ≥ 25, insulin use and 
duration  of  diabetes  >  5  years,  but  not  with  gender  or 
smoking.  In  Jordan  there  was  a  positive  and  significant 
association between hypertension and the variables of age, 
BMI and duration of diabetes, but no significant association 
was found with gender, or  smoking [12]. In patients with 
type  2  diabetes  mellitus,  insulin  users  are  at  higher  risk  
for  development  of  hypertension  [20].  The  strength  of 
association showed an approximately 2-fold increase in odds 
ratios  in  patients  using  insulin  for  more  than  10  years 
compared  with  non-users  when  analyzed  in  all  patients  in 
most  of  the  logistic  models.  The  study  by  Kern  et  al., 
provided  direct  evidence  for  the  development  of  insulin-
induced hypertension [21]. The higher rate of hypertension 
reported among our study sample is perhaps related to the 
fact  that most diabetic patients have  longstanding diabetes 
and are on insulin. 
  Until the results of  the 8
th report of the Joint National 
Committee appear, we need to stick to BP targets in diabetic 
patients  of  <  130/80  mmHg,  though  new  meta-analysis 
suggests a systolic BP treatment goal of 130 to 135 mmHg is 
acceptable [22].  
CONCLUSION 
  This study confirms that hypertension was seen in ~90% 
of diabetic patients in Iraq, and approximately half of them 
were achieving a target BP < 130/80 mmHg. 
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